Article
Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study.
EBioMedicine - 1 Jun 2024
Wang Heming, Reid Brett M, Richmond Rebecca C, Lane Jacqueline M, Saxena Richa, Gonzalez Brian D, Fridley Brooke L, Redline Susan, Tworoger Shelley S, Wang Xuefeng
Abstract excerpt
BACKGROUND: Insomnia is the most common sleep disorder in patients with epithelial ovarian cancer (EOC). We investigated the causal association between genetically predicted insomnia and EOC risk and survival through a two-sample Mendelian randomization (MR) study. METHODS: Insomnia was proxied using genetic variants identified in a genome-wide association study (GWAS) meta-analysis of UK Biobank and 23andMe....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
